Skip to content
buyModerate cluster of 4

Amy Sullivan bought $8,483 of IOBT

Chief Financial Officer at IO Biotech, Inc.. 10,250 shares at an average of $0.83, traded Dec 23, 2024, filed Dec 23, 2024.

Conviction score
40
Value
$8,483
10,250 shares
Holdings after
84,632
+14% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    CFO
    +22
  • Trade size
    $8k at market
    0
  • Relative to holdings
    Holdings up 14%
    +3
  • Price context
    No price history yet
    0
  • Cluster
    4 insiders buying within 14 days
    +15
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0000905148-24-003410, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Dec 23, 2024POpen-market purchase
Common Stock
+10,250$0.83$8,48384,632Dec 23, 2024

Related signals

Other insiders at IO Biotech, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
23Weak
IOBTbuy
IO Biotech, Inc.
Heidi Hunter
director
$21k
15,000 shares
-
43Moderate
IOBTbuy 4
IO Biotech, Inc.
Qasim Iftikhar Ahmad
Chief Medical Officer
$27k
31,350 shares
-
40Moderate
IOBTbuy 4
IO Biotech, Inc.
Devin Whittemore Smith
General Counsel
$9,720
12,000 shares
+243%
46Moderate
IOBTbuy 4
IO Biotech, Inc.
Mai-Britt Zocca
Chief Executive Officer
$10k
12,500 shares
+33%
25Weak
IOBTbuy
IO Biotech, Inc.
Brian Burkavage
Chief Accounting Officer
$10k
10,000 shares
+667%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Amy Sullivan bought $8,483 of IOBT | InsiderTell